Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective

Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-related morbidity and mortality. Recent clinical evidences suggest increased level of cytokines and chemokines targeting lung tissue as a prominent etiological factor. The immunomodulatory effect of mesenchymal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Ashim, Kashte, Shivaji, Gupta, Manu, Rodriguez, Hugo C., Gautam, Shraddha Singh, Kadam, Sachin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418088/
https://www.ncbi.nlm.nih.gov/pubmed/32780299
http://dx.doi.org/10.1007/s13577-020-00407-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418088/
https://www.ncbi.nlm.nih.gov/pubmed/32780299
http://dx.doi.org/10.1007/s13577-020-00407-w

Ejemplares similares